IMPLEMENTATION OF GLOBAL LICENSE TO AUREUS PHARMA'S KNOWLEDGE DATABASES BY GLAXOSMITHKLINE

Aureus Pharma a leading provider of knowledge management solutions to aid discovery in the life sciences industry, today announces that GlaxoSmithKline (GSK) has signed a multi-year license for Aureus Pharma's AurSCOPE Knowledge databases. Researchers at GSK's global research and development centers will gain access to Aureus' Knowledge databases including AurSCOPE GPCR, Ion Channel, hERG, and ADME/Drug-Drug Interactions. In addition, GSK has licensed the recently released AurSCOPE Kinase product making it the first customer of this knowledge base which is of major importance for oncology and other diseases. Financial details were not disclosed.
PR Newswire